|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10338|
The global cell analysis market is growing significantly due to increasing prevalence of chronic and infectious diseases, increasing research and development activities and technological advancements in cell analysis techniques. In addition, increasing usage of cell analysis in various applications, such as target identification and validation, cell identification and viability, and single cell analysis is also supporting the growth of the global cell analysis market. Large unexplored cell analysis market in emerging economies and increasing contract research outsourcing in healthcare are creating ample opportunities for the global cell analysis market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective and efficient cell analysis imaging systems.
Adoption of quantitative real-time reverse transcription polymerase chain reaction for single cell analysis is a trend in the global cell analysis market. Increasing prevalence of cancer has fuelled the demand of cell analysis instruments. Cell analysis instruments are extensively used in detection and diagnosis of cancerous cell in blood and bones. Advanced techniques of cell analysis are being used to study the cancer at the single cell level.
The global cell analysis market is categorized as product type and end-users. Based on product type, the cell analysis market is categorized as consumables and instruments. The cell analysis consumables include reagents, microplates, assay kits, and others. The cell analysis instruments include spectrophotometer, microscopes, cell counting instruments, flow cytometer, cell microarrays, quantitative real-time reverse transcription polymerase chain reaction, and others. On the basis of end-users, the global cell analysis market is categorized as pharmaceutical and biotechnology companies, contract research organizations, laboratories and hospitals, research, and academic institutes.
Some of the factors driving the growth of the global cell analysis market are increasing prevalence of infectious and chronic diseases, technological advancements in cell analysis techniques, and increasing government spending in healthcare. In addition, continuous innovations in image analysis systems and informatics are propelling the growth of the global cell analysis market. On the other hand, stringent regulatory requirements, lack of skilled professionals, and high cost of image analysis instruments are some of the factors restraining the growth of the global cell analysis market to some extent.
Geographically, North America will be leading the global cell analysis market in the coming years due to high prevalence of cancer, high research and development activities, and technological advancements in cell analysis systems. In addition, presence of large number of hospitals, pharmaceutical and biotechnology companies, and academic and research institutes is also driving the expansion of cell analysis market in North America. Asia-Pacific is the fastest growing region in the global cell analysis market. The major reasons for the fastest growth in the region are increasing prevalence of chronic and infectious diseases, increasing healthcare expenditure, and improving healthcare infrastructure. Moreover, the cell analysis market is growing rapidly due to increasing molecular biology and genetics research, and rising adoption rate of advanced cell analysis techniques in clinical diagnostics in emerging economies, such as India and China, of Asia-Pacific.